UT Southwestern Researcher Tells His CAR-T Therapy Story Ahead of Myeloma Trial – Myeloma Research News
Myeloma Research News |
UT Southwestern Researcher Tells His CAR–T Therapy Story Ahead of Myeloma Trial
Myeloma Research News As UT Southwestern and Celgene Corporation join efforts to launch a new clinical trial to evaluate a chimeric antigen receptor T–cell therapy, also known as CAR-T therapy, for multiple myeloma, Dr. Woodring Wright, a professor of cell biology and … |
